We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Norma Diagnostika Showcases Icon Hematology Analyzers at MEDLAB

By LabMedica International staff writers
Posted on 09 Feb 2017
Norma Diagnostika GmbH, a designer and supplier of blood analysis systems serving the in-vitro diagnostic (IVD) market, showcased its Icon hematology analyzers at MEDLAB 2017 held in Dubai, UAE, from February 6-9, 2017.

Norma Diagnostika’s product range consists of analyzers and reagents for clinical chemistry, hematology, as well as ion selective analyzers for medical clinics. More...
At MEDLAB 2017, the company exhibited the Icon 3, a 3-part differential hematology analyzer, and the Icon 5, a 5-part differential hematology analyzer.

The Icon 3 provides a 22-parameter complete cell blood count report, including histograms for WBC, RBC and PLT, and also measures capillary blood samples. The Icon 5 provides a 26-parameter complete cell blood count report, including RBC and PLT histograms, as wells as a 5-part WBC scattergram, using laser based flow cytometry with forward-scattered light detection and volumetric impedance measuring method. The Icon hematology analyzers use microfluidics technology, which enables reagent consumption to be reduced by more than 70% as compared to other analyzers on the market.

Both the Icon hematology analyzers have one of the smallest dimensions within their class, which allows them to be used in emergency departments, ICUs, private clinics, blood banks, and mobile care units.


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.